Kwality Pharmaceuticals Ltd

we wish to inform you that at the Board Meeting held today i.e. on Monday May 19 2025 the Board of Directors of the Company have inter alia Considered and approved the Audited Standalone and Consolidated Financial Results for the Quarter and Financial Year Ended 31st March 2025. we are enclosing herewith:a. Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year Ended 31st March 2025. b. Statement of Assets and Liabilities as at March 31 2025 and Statement of Cash Flows for the Financial Year Ended 31st March 2025.c. Declaration pursuant to Regulation 33(3) (d) of the SEBI (LODR) Regulations 2015 regarding unmodified opinion of the Statutory Auditors on the Annual Financial Results for the Financial Year ended on 31st March 2025.d. Auditors reports on the Audited Financial Results on Standalone and Consolidated basis.